ArticleOncotarget2017

Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.

Hui Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.